Western Blotting Market Size, Share, Industry Trends and Forecast to 2030

Western Blotting Market Size & CAGR in 2021

The global western blotting market is projected to reach a value of USD 870 million by the end of 2021, with a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. The increasing demand for personalized medicine and the rise in research activities in the pharmaceutical and biotechnology sectors are driving the growth of the western blotting market.

COVID-19 Impact on the Western Blotting Market

The outbreak of the COVID-19 pandemic has had a significant impact on the global western blotting market. The disruptions in the supply chain, closure of research laboratories, and focus on COVID-19 research have resulted in a temporary slowdown in the market growth. However, with the gradual reopening of economies and resumption of research activities, the western blotting market is expected to recover and witness steady growth in the post-pandemic period.

Western Blotting Dynamics

The western blotting technique is a vital tool in molecular biology and biochemistry research for the detection and analysis of proteins. The increasing prevalence of chronic diseases, such as cancer and infectious diseases, is driving the demand for western blotting in diagnostic and research applications. Technological advancements in western blotting kits and reagents are also contributing to market growth.

Segments and Related Analysis

The western blotting market can be segmented based on product type, application, end-user, and region. Product types include consumables, instruments, and software. Applications of western blotting include research applications, diagnostic applications, and others. End-users of western blotting products are academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and others.

By Region Analysis

The western blotting market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market due to the presence of key market players, increasing research funding, and advanced healthcare infrastructure. Asia Pacific is expected to witness significant growth during the forecast period due to rising investments in research and development and increasing adoption of western blotting technology.

Key Market Players and Competitive Landscape

The key players in the global western blotting market include Thermo Fisher Scientific, Bio-Rad Laboratories, GE Healthcare, PerkinElmer, Merck Millipore, Abcam, LI-COR Biosciences, Advansta, Roche Diagnostics, and Azure Biosystems. These companies are focusing on product innovations, strategic partnerships, and mergers and acquisitions to maintain their market position and drive growth.

Recent Happenings in the Western Blotting Market

1. In April 2021, Thermo Fisher Scientific launched a new range of western blotting kits with improved sensitivity and specificity for protein detection. 2. Bio-Rad Laboratories announced a collaboration with a leading research institute to develop advanced western blotting techniques for cancer biomarker detection. 3. GE Healthcare introduced a novel western blotting system with automated data analysis features to streamline protein analysis workflows in research laboratories. 4. Merck Millipore expanded its portfolio of western blotting reagents with the launch of a high-performance stripping buffer for membrane reprobing. 5. Abcam partnered with a biopharmaceutical company to develop customized western blotting solutions for drug discovery and development applications.